Dosimetric verification of the dose calculation algorithms in real time prostate brachytherapy

被引:3
作者
Mocna, Marta [1 ]
Zwierzchowski, Grzegorz [1 ]
机构
[1] Greater Poland Canc Ctr, PL-61866 Poznan, Poland
关键词
real time brachytherapy; dose verification; dose measurements; semiconductor detectors;
D O I
10.1016/S1507-1367(10)60013-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND: During real time prostate brachytherapy different calculation algorithms can be used which gives the opportunity to modulate the dwell times and positions of the source and consequently the dose distribution and values of therapeutic indices [1]. AIM: The aim of this study was the dosimetric verification (in-phantom) of three optimization algorithms for dose calculation during real-time prostate brachytherapy. MATERIALS/METHODS: Three optimization algorithm were evaluated: geometric optimization (GO), inverse optimization (IO) and blind inverse optimization (BIO). Then treatment plans for the tissue-equivalent phantom were prepared. For each plan the same CTV, organs at risk (OARs: urethra, rectum), number of needles and geometry of implant were used. RESULTS: Measured mean doses and their standard deviations for GO, IO and BIO were respectively: 11.13 Gy and 0.01 Gy, 15.71 Gy and 0.01 Gy, 14.74 Gy and 0.02 Gy for the urethra and 10.11 Gy and 0.01 Gy, 8.97 Gy and 0.01 Gy, 8.70 Gy and 0.01 Gy for the rectum. Comparison between doses measured by semiconductor detectors and calculated doses revealed differences in the range from 0.10 Gy between doses compared in the urethra for IO and BIO even to 2.46 Gy for GO for the same analyzed organ. For the rectum these differences were between 0.32 and 0.66 Gy. CONCLUSIONS: Qualitative comparative analysis performed for a phantom study for 3D-CBRT prostate treatment proved the correctness of verified optimization algorithms implemented in Oncentra Prostate vs. 3.0.9.
引用
收藏
页码:275 / 279
页数:5
相关论文
共 19 条
[1]   Long-term outcome of high dose rate brachytherapy in radiotherapy of localised prostate cancer [J].
Åström, L ;
Pedersen, D ;
Mercke, C ;
Holmäng, S ;
Johansson, KA .
RADIOTHERAPY AND ONCOLOGY, 2005, 74 (02) :157-161
[2]  
Baltas D, 2007, SWIFT ONC PROST US M
[3]   High-dose-rate intensity-modulated brachytherapy with external beam radiotherapy for prostate cancer: California endocurietherapy's 10-year results [J].
Demanes, DJ ;
Rodriguez, RR ;
Schour, L ;
Brandt, D ;
Altieri, G .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 61 (05) :1306-1316
[4]  
Fijalkowski M, 2005, NOWOTWORY J ONCOLOGY, V55, P115
[5]  
Fijalkowski M, 2005, NOWOTWORY, V55, P58
[6]   Patterns of care for brachytherapy in Europe (PC BE) in Spain and Poland: Comparative results [J].
Guedea, Ferran ;
Ventura, Montse ;
Polo, Alfredo ;
Skowronek, Janusz ;
Malicki, Julian ;
Bulski, Wojciech ;
Zwierzchowski, Grzegorz ;
Lopez Torrecilla, Jose ;
Bilbao, Pedro ;
Maria Borras, Josep .
REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 2007, 12 (01) :39-45
[7]   High dose rate brachytherapy in combination with external beam radiotherapy in the radical treatment of prostate cancer: initial results of a randomised phase three trial [J].
Hoskin, Peter J. ;
Motohashi, Kate ;
Bownes, Peter ;
Bryant, Linda ;
Ostler, Peter .
RADIOTHERAPY AND ONCOLOGY, 2007, 84 (02) :114-120
[8]   High dose rate afterloading brachytherapy for prostate cancer: catheter and gland movement between fractions [J].
Hoskin, PJ ;
Bownes, PJ ;
Ostler, P ;
Walker, K ;
Bryant, L .
RADIOTHERAPY AND ONCOLOGY, 2003, 68 (03) :285-288
[9]  
ICRU, 1992, 48 ICRU
[10]  
Kanikowski M, 2007, UROL POL, V2, P5